Beauty Health Company (The) Overview
Beauty Health Company (The) (SKIN) has a P/E ratio of -2.96, below the Healthcare sector average of 25.93.
Get informed when a big investor buys or sells
+ Follow-2.96
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Beauty Health Company (The) (SKIN) currently reports a P/E ratio of -2.96. That is below the Healthcare sector average of 25.93. Use the charts on this page to explore Beauty Health Company (The)'s P/E ratio history and peer comparisons.
Beauty Health Company (The)'s P/E ratio of -2.96 is lower than the Healthcare sector average of 25.93. That is roughly 111.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Beauty Health Company (The)'s market price to a fundamental measure such as earnings, sales, or book value. At -2.96, SKIN can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -2.96, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.93. From there, open related valuation or income-statement pages for Beauty Health Company (The), and consider following SKIN for alerts when major investors trade the stock.
Beauty Health Company (The) is classified in the Healthcare sector. On P/E ratio, it currently shows -2.96 versus a sector average near 25.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SKIN with unrelated industries.
